Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astrazeneca
6
×
life sciences
national blog main
novartis
6
×
san francisco blog main
san francisco top stories
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
boston top stories
clinical trials
fda
startups
amgen
deals
eli lilly
pfizer
sanofi
takeda pharmaceutical
allergan
What
bio
roundup
acquisitions
ceo
daniel
drug
drugs
gilead
o’day
sciences
seven
alzheimer’s
announced
august
available
away
biggest
biological
biologics
biotech
bringing
build
busy
buy
can’t
cells
ceos
clears
collabs
company’s
congress
convenience
covid
days
dc
deal
debut
decisions
democrats
devices
Language
unset
Current search:
novartis
×
astrazeneca
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel